Expert Review of Respiratory Medicine

Papers
(The TQCC of Expert Review of Respiratory Medicine is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis180
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2175
False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives80
Pulmonary fibrosis secondary to COVID-19: a narrative review61
Extrapulmonary tuberculosis55
Artificial intelligence and machine learning in respiratory medicine52
Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis44
Reported quality of life in countries with cases of COVID19: a systematic review41
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential39
Rehabilitation of patients with COVID-1939
Diagnostic approaches in COVID-19: clinical updates39
Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis35
The long-lasting effects of the acute respiratory distress syndrome32
The COVID-19 pandemic: a target for surfactant therapy?31
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review30
Role of fever and ambient temperature in COVID-1929
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management29
Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies29
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study28
Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management28
An overview of the available treatments for chronic cavitary pulmonary aspergillosis27
Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients25
COPD patients in a COVID-19 society: depression and anxiety25
Ten challenging questions about SARS-CoV-2 and COVID-1924
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?23
Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments22
Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis21
Smoking-associated interstitial lung disease: update and review21
Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis21
Endo-phenotyping of COPD patients20
COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice18
Influences of environmental exposures on individuals living with cystic fibrosis18
Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-8518
Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation18
Ibuprofen and COVID-19 disease: separating the myths from facts18
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?17
The right interface for the right patient in noninvasive ventilation: a systematic review17
COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life17
Chronic obstructive pulmonary disease in HIV17
Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care17
The impact of maternal asthma during pregnancy on fetal growth and development: a review17
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies17
Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment17
Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India16
Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach16
Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease16
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients16
Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis16
What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions15
Lung function parameters among Australian Aboriginal ‘apparently healthy’ adults: an Australian Caucasian and Global Lung Function Initiative (GLI-2012) various ethnic norms comparative study15
Influences of environmental exposures on preterm lung disease15
Understanding the relationships between environmental factors and exacerbations of COPD15
Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases15
Innate and adaptive immune responses in respiratory virus infection: implications for the clinic15
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials15
Covid-19: a comprehensive review of a formidable foe and the road ahead15
Impact of long-term exposure wildfire smog on respiratory health outcomes15
Role of the mucins in pathogenesis of COPD: implications for therapy14
Machine learning in asthma research: moving toward a more integrated approach14
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma14
Advances in the diagnosis of fungal pneumonias14
Depression and anxiety in patients with interstitial lung disease13
Tuberculosis related stigma in India: roadblocks and the way forward13
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer13
Could E-cigarette vaping contribute to heart disease?13
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases13
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients13
Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease12
The rising of allergic respiratory diseases in a changing world: from climate change to migration12
An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation12
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD12
COPD in Biomass exposed nonsmokers: a different phenotype12
Recent developments in the pathobiology of lung myofibroblasts12
Mediastinal lymphadenopathy: a practical approach12
Medical thoracoscopy in the diagnosis of pleural disease: a guide for the clinician12
DNA methylation in pulmonary fibrosis and lung cancer11
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy11
Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China11
HIV TB coinfection - perspectives from India11
Sex steroid hormones and asthma in women: state-of-the-art and future research perspectives11
Pulmonary manifestations of gastroesophageal reflux disease11
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy11
Cognitive impairment in COPD: an often overlooked co-morbidity11
Tuberculosis in children with severe acute malnutrition11
Pediatric bronchoscopy: recent advances and clinical challenges11
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy11
Benralizumab: an updated treatment of eosinophilic asthma11
An effective drug against COVID-19: reality or dream?11
Association between sarcoidosis and diabetes mellitus: a systematic review and meta-analysis10
Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis10
Comorbidities and mortality risk factors for patients with bronchiectasis10
Role of acute exacerbations in skeletal muscle impairment in COPD10
Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population10
Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-1910
The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-1910
Myofunctional therapy for OSA: a meta-analysis10
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-1910
SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond10
Granulomatous lung disease: clinical aspects10
Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies10
COVID-19 ‘asymptomatic’ patients: an old wives’ tale9
Determining the appropriate treatment for different EGFR mutations in non-small cell lung cancer patients9
The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis9
Bilevel and continuous positive airway pressure and factors linked to all-cause mortality in COVID-19 patients in an intermediate respiratory intensive care unit in Italy9
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry9
A comprehensive clinical guide forPneumocystis jiroveciipneumonia: a missing therapeutic target in HIV-uninfected patients9
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study9
The effect of teach-back training intervention of breathing exercise on the level of dyspnea, six-minutes walking test and FEV1/FVC ratio in patients with chronic obstructive pulmonary disease; a rand8
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment8
Transbronchial Lung Cryobiopsy in children8
Step-up and step-down approaches in the treatment of asthma8
Recommendations for COPD management in Central and Eastern Europe8
Effectiveness, safety and efficacy of INTELLiVENT–adaptive support ventilation, a closed–loop ventilation mode for use in ICU patients – a systematic review8
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK8
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR8
Management of COVID-19 from the pulmonologist’s perspective: a narrative review8
Obstructive sleep apnea: personalizing CPAP alternative therapies to individual physiology8
0.043938159942627